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Excessive inflammation during pregnancy can exert powerful effects on the 
developing fetus by altering embryonic, fetal, and placental growth and development, 
predisposing the fetus to adverse birth outcomes and long-term health complications. 
An anti-inflammatory diet and proper prenatal supplementation could be a promising 
avenue to combat the inflammatory state pregnancy induces, particularly in obese 
women. However, there is a lack of data linking maternal environmental mediators of 
inflammation, such as diet, to birth outcomes and behavior in offspring. We examined 
the association among prenatal nutrition during the 22nd and 37th week of gestation and 
birth outcomes, as well as negative affect in infants 1 month after birth, in a cohort of 
55 mother-child pairs. We found pro-inflammatory diets in the 3rd trimester and 
throughout the duration of participants pregnancy, as measured by the Dietary 
Inflammatory Index (DII), were associated with higher APGAR scores at 5-minutes. 
Maternal under-supplementation of DHA and EPA and increased iodine 
supplementation during the 2nd trimester was associated with higher APGAR scores at 5 
minutes, while increased iodine supplementation in the 3rd trimester was associated with 




3rd trimester was associated with higher levels of infant negative affectivity 1-month 
post-partum. This data will add to the broader literature surrounding prenatal diet and 
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Adiposity Amount of bodily fat. 
Air displacement 
plethysmography 
A technique for measuring body composition that utilizes the 
volume and pressure of displaced air by the body when it is 
placed in a plethysmograph machine.  
APGAR Score  Appearance, pulse, grimace, activity, and respiration assessment 
occurring 1 and 5 minutes immediately after birth. Provides a 
convenient and accepted method for reporting the status of 
newborns and can indicate the response to resuscitation if 
needed. Each category is rated from 0-2 and a score between 7-
10 at 5 minutes are indicative of good health at birth.   
Cytokines  Regulators of response to infection, immune responses, 
inflammation, and trauma in the body that can promote healing 
(anti-inflammatory) or make disease worse (pro-inflammatory).  
Dietary 
inflammatory 
index (DII)  
A method of assessing the inflammatory potential of an 
individual diets. Has been associated with concentrations of 
circulating cytokines (i.e. more pro-inflammatory has higher 
levels of pro-inflammatory cytokines).   
Gestation  Period between conception to birth. A normal gestational period 
lasts between 38 and 42 weeks.  
Macrophage  A type of white blood cell that surrounds and kills 
microorganisms, removes dead cells, and stimulates the action of 
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other immune cells through the release of chemical signals. Can 
have either pro-inflammatory or anti-inflammatory effects in the 




Diets higher in fruits, vegetables, fish, poultry and whole grain 
bread that are associated with lower levels of circulating pro-
inflammatory cytokines  
Negative 
affectivity  
A broad behavioral term that can be summarized as feelings of 
emotional distress and is often defined by feelings of anxiety, 
sadness, fear, guilt, etc.  
Neural tube 
defects (NTD’s) 
Severe birth defects of the brain and spine that occurs when the 
neural tube does not close properly. The 2 most common are 
spina bifida and anencephaly (a brain defect).  
Neutrophils  A type of white blood cell that form an essential part of the 
innate immune system and help fight infection. 
Perinatal  Pertaining to the period immediately before and after birth, 
roughly starting between the 20th and 28th weeks of gestation and 
ending 1 to 4 weeks after birth.  
Postnatal  Period occurring after birth, often used in reference to the 
newborn.  
Preeclampsia  A potentially dangerous pregnancy complication that is 
characterized by high blood pressure and signs of damage to 




pregnancy. When untreated, preeclampsia can be fatal and create 
harmful conditions for both the mother and fetus.  
Size for 
gestational age  
Categorical division of newborn size based on birthweight and 
gestational age. Small for gestational age (SGA) are infants 
below the 10th percentile in weight for their gestational age and 
large for gestational age (LGA) are infants above the 90th 
percentile in weight for their gestational age.  
Western diet  Pro-inflammatory diet commonly consumed in the United States 
that is defined by a diet that is rich in red meat, high in fat, and 
high in simple carbohydrates. The western diet is associated with 
higher levels of circulating pro-inflammatory cytokines in 







According to accumulating evidence and the developmental origin of health and 
disease hypothesis, during pregnancy variation in nutrition, maternal body size, and 
exposure to toxins can exert powerful effects on the developing fetus that impacts the 
child’s lifelong health (Langley-Evans & McMullen, 2010). These factors alter 
embryonic, fetal, and placental growth and development, predisposing the fetus to more 
adverse birth outcomes and long term health complications like cardiovascular disease, 
obesity, type 2 diabetes, and cancer (McCullough et al., 2017). The interplay of various 
maternal environmental exposures during gestation posits a public health importance for 
moderating potential long-term health and development consequences during the 
embryonic and postnatal period. A potential avenue to improve fetal outcomes and 
development is through the reduction of maternal inflammation during gestation.  
This project aims to evaluate the extent to which poor maternal nutrition, 
independently or in combination with increased maternal adiposity, predicts birth 
outcomes for both the mother and the infant. Additionally, I will examine how changes 
in the in-utero environment induced by poor nutrition, independently or in combination 
with increased maternal adiposity, programs altered infant behavior, in particular 
negative affectivity, 1-month after birth. Within these two aims, I hypothesize that fetal 
developmental exposure to a pro-inflammatory diet and increased adiposity during 
gestation, increases in-utero exposure to inflammation, leading to more adverse birth 
outcomes (e.g. delivery type, gestational age, birth weight, etc.). Additionally, fetal 
exposure to improper prenatal supplementation and increased adiposity causes 




hypothesize that fetal exposure to a pro-inflammatory diet and increased maternal 
adiposity during gestation leads to early indices of neurodevelopmental problems, such 
as higher levels of negative affect and regulatory problems in infants 1-month post-
partum. Also, improper supplementation and increased maternal adiposity during 
gestation leads to early indices of neurodevelopmental problems, such as higher levels 





Obesity and Pregnancy  
Metabolic and physiologic changes that occur during pregnancy induces the 
body into an inflamed state and has the potential to compound inflammation that also 
occurs due to obesity. Inflammation occurs as an attempt by the body to repair itself 
following an infection or injury that alters bodily homeostasis (Segovia et al., 2014). 
The body uses immune cells (macrophages, B-cells, T-cells) to repair itself and 
coordinates these cells using cytokines, a type of inflammatory signaling molecule 
(Libby, 2008). Cytokines can be either pro- or anti-inflammatory and commonly studied 
pro-inflammatory cytokines are interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-
 𝛼𝛼, and C-reactive protein (CRP) (Dinarello, 2000). Inflammation is important for 
protecting the body against pathogens and injury; however, it can also contribute to the 
progression and continuation of many chronic diseases. Obesity is an example of this 
through the induction of chronic, low-grade inflammation in the body (Schmatz et al., 
2010). As body mass index (BMI) increases, the amount of fat, or adipose tissue, in the 
body increases accordingly. It is known that there is increased concentrations of pro-
inflammatory cytokines (IL-6, IL-8, TNF-𝛼𝛼, and CRP) in people with obesity, 
indicating that inflammation is above normal in this population (van der Burg et al., 
2016). The underlying mechanism is that as the amount of adipose tissue increases, 
adipocytes (fat cells) release an increased number of pro-inflammatory cytokines and 
growth factors, called adipokines, that systemically affect the endocrine environment by 
inducing the body to release macrophages and begin tissue necrosis (Schmatz et al., 
2010). This process becomes cyclic where more pro-inflammatory mediators are 
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released, perpetuating a chronic state of inflammation in the body (Schmatz et al., 
2010).  
 Due to the prevalence of obesity among pregnant women, it is essential to 
understand how the chronic inflammation of obesity couples with the already pro-
inflammatory state of pregnancy and other environmental factors. In the United States, 
obesity (body mass index of 30 and above) is the most common adverse condition 
among pregnant women and occurs in almost a third of pregnancies (Catalano & 
Shankar, 2017). In obese women, fetal anomalies and deviations in fetal growth rates 
are more common, suggesting the maternal adiposity (percent fat) during gestation can 
affect development throughout pregnancy (King, 2006). Maternal inflammation creates 
a modified in-utero environment, increasing the risk of experiencing costly 
complications like miscarriages, gestational hypertension, preeclampsia, caesarean 
section, longer postpartum hospital stays, and gestational diabetes during pregnancy 
and, in turn, placing the child at risk for future health and development complications 
(Catalano & Ehrenberg, 2006).  
Obesity and pregnancy contribute to levels of inflammation individually; 
however, the mechanism of this is still unknown. It is believed that during pregnancy, 
the maternal immune system is altered significantly, increasing the concentrations of 
macrophages, neutrophils, and serum cytokines (Schmatz et al., 2010). This increased 
maternal immune response is believed to be an evolutionary mechanism that assists in 
aborting unhealthy pregnancies or allowing healthy ones to progress (Schmatz et al., 
2010). As the pregnancy progresses and the placenta grows and develops, higher 




ensure that the maternal immune system does not see the placenta as a foreign invader 
(Redman et al., 1999). The immune system response must maintain a delicate balance 
between an enhanced immune response and immunosuppressive factors to ensure a 
healthy maternal-placental interaction throughout gestation (Schmatz et al., 2010). This 
delicate balance is altered by the increased inflammatory response to increased maternal 
adiposity and can create harmful conditions for both the mother and fetus (Figure 1). 
Higher concentrations of pro-inflammatory cytokines has been associated with multiple 
pregnancy complications such as: premature fetal membrane rupture, premature labor, 
hypertension, and preeclampsia (Pieczyńska et al., 2020). For example, preeclampsia, a 
serious pregnancy complication that is characterized by hypertension, coagulation 
abnormalities, and a decrease of uteroplacental blood flow, is more common among 
obese women during gestation (Redman et al., 1999). It is believed that this occurs due 
to increased levels of CRP, a pro-inflammatory cytokine, and other circulating 
cytokines that interfere with placentation, the formation and implantation of the 
placenta in the uterus, predisposing the body to preeclampsia (Schmatz et al., 2010). As 
pregnancy already induces a state of inflammation in the body, the interplay between 
obesity, pregnancy, diet, and the developing fetus could give insight on how to reduce 








Figure 1: Associations among obesity, pregnancy, inflammation, and disease. Adapted 
from Schmatz et al. (2010). 
Both pregnancy and obesity cause an increased immune response, as shown by 
increasing levels of pro-inflammatory cytokines and immune cells. These effects are 
additive and result in an overall higher inflammatory state for the obese mother that can 
lead to more adverse birth outcomes for both the mother (e.g. preeclampsia, gestational 
diabetes mellitus, etc.) and the child (e.g. low APGAR, NICU admission, etc.). 
 
Diet  
Maternal diet during gestation could impact fetal development via inflammatory 
pathways. The link between diet and inflammation is well established in non-pregnant 
populations and the ability for environmental dietary sources of inflammation to couple 
with the inflammatory state that pregnancy induces, suggests that this link persists in 




style” diet that is consumed is rich in red meat, high in fat, and high in simple 
carbohydrates, all of which may contribute to the increasing concentration of 
inflammatory cytokines (Pieczyńska et al., 2020). This Western diet has been associated 
with higher levels of circulating concentrations of CRP and IL-6 in nonpregnant adults, 
but this link has yet to be explored in pregnant populations (Sen et al., 2016). Diets 
higher in fruits, vegetables, fish, poultry and whole grain bread are classified as a 
“Mediterranean diet” and typically those who consume these diets have a lower 
concentration of CRP (Lopez-Garcia et al., 2004). Diets high in specific nutrients like 
omega-3 fatty acids, fiber, vitamin E, vitamin C, 𝛽𝛽-carotine, and magnesium have all 
been associated with lower levels of inflammation, obesity, and cardiovascular disease 
(Sen et al., 2016). The role that diet and nutrition have on inflammatory markers in 
nonpregnant individuals suggests that the same relationship could exist among maternal 
diet, pregnancy, and birth outcomes due to the ability of the in-utero environment to 
contribute substantially to the growth and development of the fetus.  
A common way to assess the inflammatory potential of an individual’s diet is 
using the Dietary Inflammatory Index (DII), which assesses a person’s diet in terms of 
pro- and anti-inflammatory foods that are eaten and generates an overall inflammatory 
score (Shivappa et al., 2014). The DII is known to be an accurate predictor of the level 
of multiple inflammatory markers, including CRP, IL-10, TNF-alpha, and IL-6 
(Pieczyńska et al., 2020). Current research has found that the DII has been associated 
with levels of CRP in pregnant populations, but the concentrations of other cytokines 
has not yet been established (McCullough et al., 2017). By utilizing the DII, we can 




pregnant women and identify the impact of dietary choices on growth and development 
during gestation and beyond.   
Supplementation  
Many metabolic changes occur in pregnancy like increased metabolic rate, 
lower insulin synthesis, increased lipolysis, and increased blood volume to help nourish 
and grow the fetus (Lowensohn et al., 2016). Most women take prenatal supplements to 
help fill this new metabolic demand. These supplements are high in nutrients and 
vitamins to create an in-utero environment that maximizes fetal development and 
maternal adaptation to a state of pregnancy (Christian et al., 2015). The recommended 
levels of various supplements and nutrients is well known, however, the interaction 
between supplementation and the diet consumed during gestation is not well understood 
in terms of birth outcomes.  
Even though supplementation during pregnancy is common practice, the 
composition of prenatal vitamins is often variable. The National Health and Nutrition 
Examination Survey (NHANES) is a national representative, cross-sectional survey of 
US citizens conducted by the CDC to determine nutritional information, releasing data 
in 2 year cycles (NHANES, 2021). This survey gives insight to the average nutritional 
behaviors of pregnant women in the US, specifically their consumption of various 
micronutrients from both dietary and supplement sources. According to a study 
conducted in 2013 using NHANES data, 75% of pregnant women reported using 
prenatal supplements (Branum et al., 2013). However, this high percentage can be 
deceiving due to the variable nutrient content and nutritional composition in dietary 




receive adequate micronutrient intake during pregnancy so harmful conditions due to 
under or over-supplementation are prevented.  Based on an examination of NHANES 
data from 2001-2014, 10% of pregnant women were at risk for inadequate intake of 
thiamin, vitamin B12, and vitamin B6, while only 8% were meeting recommended 
amounts of choline intake (Bailey et al., 2019). It was also found that 33.4% pregnant 
women exceeded the upper limit for folic acid consumption, due to over-
supplementation (Bailey et al., 2019). The robust set of data from NHANES surveys 
show a clear misuse of supplementation among most pregnant women, calling for a 
reevaluation of prenatal supplementation in the US that takes both contemporary 
nutritional composition and dietary supplementation in account during this critical 
developmental period.  
From fetal development to early childhood, exposures occurring in-utero and 
during the postnatal period, have a significant effect on lifelong health and wellbeing 
(Procter & Campbell, 2014). This emerging perspective emphasizes how critical 
creating an optimal in-utero environment is, not only for the prevention of adverse birth 
outcomes, but also for promotion of mental and physical health for the entirety of the 
offspring’s life. My project will add to the expanding literature of the effects of 
micronutrient deficits on the regulatory abilities of infants 1-month post-partum by 
examining the nutritional and supplement intake throughout the pregnancy of the 
mother. The developmental importance of the micronutrients I examine for my project 
are summarized in Table 1. The subset of micronutrients that I have selected have well 
known impacts on the neurodevelopment of the fetus and can be found in most 




Table 1: Recommended micronutrient supplementation during pregnancy from the 
American College of Obstetrics (ACOG) and American Pregnancy Association, 
including the developmental importance of the nutrient (Nutrition During Pregnancy, 
n.d.; “Pregnancy Vitamins and Nutrients,” 2012; Hovdenak & Haram, 2012; Greenberg 
et al., 2008).  
Micronutrient Dosage Developmental Impact 
Iodine  220 mcg  Essential for healthy 
brain development  
Choline 450 mg Important for 
development of fetus’s 
brain and spinal cord  
B6 1.9 mg Maintains nervous 
system  
B12 2.6 mcg Helps prevent birth 
defects of the brain and 
spine 
Folic Acid 400-800 mcg* Supports general 
growth and 
development of fetus 
and placenta  
Thiamine (B-1) 1.4 mg  Essential for metabolic 
and cellular function, 





DHA 200 mg Essential for 
neurodevelopment  
DHA+EPA  300 mg  Combination increases 
utilization of DHA 
*For folic acid supplementation, any amount between 400 to 800 mcg is typically safe 
for pregnancy. 
 Iodine 
 During pregnancy, Iodine is essential for the production of thyroid 
hormones and is found in most prenatal vitamins (Zhou et al., 2013). Thyroid hormones 
are important for ensuring proper growth and development of the fetus and severe 
deficiency is the cause of congenital hypothyroidism, stunting both growth and mental 
ability (Melse-Boonstra et al., 2012). This deficiency can disrupt fetal neurogenesis, 
neuronal migration, synaptogenesis, and myelination, all of which are essential for 
proper brain development and function that can impact the fetus long after birth (Vohr 
et al., 2017). Iodine plays a significant role in fetal brain development and is commonly 
under consumed globally, yet its effects have not yet been adequately addressed. It is 
currently estimated that iodine deficiency ranks third on the list of causes that reduces 
children’s developmental potential, specifically their neurological development, 
illustrating how significant this micronutrient is during embryonic development 
(Walker et al., 2007). Even though iodine deficiency has commonly affected developing 
countries, it is on the rise in the United States, United Kingdom, and Australia, 
countries where iodine deficiency had previously under control (Zimmermann, 2009). 
In these countries, many foods are fortified with iodine (i.e. salt and dairy) as a means 
to increase dietary intake and reduce deficiencies (Zimmermann, 2009). However, the 
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rise of commercially processed foods that commonly contain non-iodized salt and 
efforts to reduce salt intake due to concerns about cardiovascular health have 
contributed to the rising levels of iodine deficiency in the United States (Pearce, 2015). 
 Choline 
 Another important micronutrient to consume during pregnancy is 
choline, responsible for structural integrity and signaling functions of cell membranes 
(Rajarethnem et al., 2017). It also plays a large role in neurotransmission, neural tube 
closure, hippocampal development, signaling to neurons and liver cells, and overall 
metabolism (Rajarethnem et al., 2017). Because of choline’s significant role in many 
bodily processes, it is vital that it is consumed during gestation in order to support fetal 
brain development. In animal models, it has been found that perinatal supplementation 
of choline enhances spatial and temporal cognition across the rodents lifespan and its 
supplementation during pregnancy causes a significant increase in the number of 
hippocampal neurons (Rajarethnem et al., 2017). Despite the known benefits of choline 
supplementation during gestation for fetal brain development, it is estimated that only 
8.5% of women in the US meet the adequate intake of choline during pregnancy (King 
et al., 2019). The pervasive under supplementation in human pregnant populations calls 
for the investigation of its impacts on the fetal brain and development throughout 
childhood.  
 Vitamin B6 
 Pyridoxine, commonly known as vitamin B6, is another micronutrient 
essential for fetal development given its role in protein metabolism in the developing 




States, B6 is commonly found in many foods like fortified cereals, potatoes, bananas, 
meat, poultry, and fish (Dror & Allen, 2012). For the Western diet, it is estimated that 
approximately 75% of B6 is bioavailable, meaning that only 75% of the dietary B6 we 
consume can be actively used by our bodies (Dror & Allen, 2012). During pregnancy, 
however, B6 consumption from diet alone is no longer sufficient and supplementation is 
required, having a bioavailability of approximately 90% (Dror & Allen, 2012). In 
animal models, offspring that experienced B6 deficiency during the prenatal period 
experienced higher rates of lower body weight, skeletal defects, convulsions, and 
impaired motor development (Aycock & Kirksey, 1976). In humans, fetal 
concentrations of B6 are higher than B6 concentrations in the mother from the second 
trimester until birth and this sequestration suggests its importance in fetal development 
(Shane & Contractor, 1975). After birth, B6 is further supplemented to the developing 
infant via breast milk and continues to increase throughout the duration of lactation, 
further demonstrating the importance of this micronutrient prenatally and perinatally 
(Sakurai et al., 2005).  
 Vitamin B12 
 Another relevant micronutrient during gestation is cobalamin, B12, 
which is naturally occurring in most animal products (Dror & Allen, 2012). During 
gestation, maternal metabolism prioritizes B12 availability for the fetus and it is 
concentrated in the placenta and is transferred to the fetus down a concentration 
gradient instead of becoming stored in the maternal liver (Dror & Allen, 2012). 
Multiple case studies have demonstrated the effect of severe vitamin B12 deficiency on 




neurological deficiencies impacting the CNS, like impaired motor development, 
demyelination, and, in severe cases, brain atrophy (Black, 2008; Chandyo et al., 2017). 
In addition, maternal deficiency has been linked to increased risk of common pregnancy 
complications like low birth weight, spontaneous abortion, neural tube defects (NTDs), 
and more (Chandyo et al., 2017). In cases of moderate deficiency, little is known about 
the consequences of maternal deficiency on fetal brain myelination, neurodevelopment, 
and cognitive function of infants postnatally (Chandyo et al., 2017). In the United States 
and other developed countries where severe B12 deficiencies are more unlikely, it is 
critical to understand how moderate B12 deficiencies impact development of the fetus 
and into infancy.  
 Folic Acid 
 One of the most commonly discussed micronutrients during pregnancy is 
folic acid, a nutrient that is crucial for proper early brain development and prevention of 
NTDs (Gao et al., 2016). In North America, most of our diet contains folic acid through 
food fortification and we consume an average daily amount of 138 micrograms 
(Chitayat et al., 2016). However, as previously mentioned, during pregnancy metabolic 
demand for many nutrients increase to levels that cannot be met by diet alone and 
supplementation needs to occur. For folic acid specifically, the high recommended 
value stems from fetal demands and it is actively transported into the placenta, 
concentrating it in the fetal brain (Gao et al., 2016). It has been found that women who 
are taking prenatal multivitamins that contain folic acid are associated with a decreased 
risk of several congenital anomalies, beyond just NTDs (Ingrid Goh et al., 2006). This 
includes protecting the fetus and infant from impaired neurodevelopment, including 
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autism spectrum disorders (ASD) in children and an overall improvement in cognitive, 
intellectual, and motor function (Gao et al., 2016). Folic acid has the ability to foster 
neurodevelopment in the fetus and can continue to benefit neurodevelopment of the 
infant into childhood, indicating how essential proper supplementation of this 
micronutrient is.  
 Thiamine 
 Another important B vitamin during pregnancy is thiamine, an essential 
micronutrient for metabolic and cellular function, especially within the developing brain 
(Hovdenak & Haram, 2012). Thiamine is actively transported, via placental transport 
systems, and becomes concentrated in fetal blood at higher levels then maternal blood 
(Hovdenak & Haram, 2012). In animal models, thiamine deficiency causes several brain 
impairments, including cerebellar damage and memory impairment (Oliveira et al., 
2007). The mechanisms of this damage are unknown, but it is postulated that thiamine 
deficiency during the prenatal and postnatal period could create disturbances of cellular 
differentiation, axonal growth, and synapses formation that could induce cellular 
deficits due to poor development of axons and synapses that are dependent on thiamine 
availability in the brain (Bâ et al., 2005). The effects of thiamine deficiencies on brain 
development during gestation have been well studied in animal models and these 
consequences can also be seen in human populations (Whitfield et al., 2018). The risks 
and consequences of thiamine deficiencies are highest in the first year of life due to 
exclusive breastfeeding where thiamine content is low in breastmilk and infants are 
unable to obtain adequate amounts of this micronutrient (Whitfield et al., 2018). Infant 
thiamine concentrations are further depleted due to the increased metabolic activity in 
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the first few months of life, causing life-long developmental motor, language, cognitive 
delays (Fattal-Valevski et al., 2009).  
 Omega-3 Fatty Acids 
 One of the most well-known micronutrients supplemented during 
pregnancy is docosahexaenoic acid (DHA), an omega-3 fatty acid that is critical for 
fetal neurodevelopment (Rogers et al., 2013). Typically, omega-3’s are consumed 
naturally from seafood; however, most pregnant women cannot get enough DHA from 
their diet due to recommended restriction of seafood consumption during pregnancy 
because of possible mercury exposure (Greenberg et al., 2008). The mechanism of how 
the fetus utilizes DHA is relatively well known. During the 3rd trimester, DHA is 
preferentially transported to the fetus, coinciding with the later stages of brain and 
retinal maturation (Rogers et al., 2013). When fetal DHA levels are inadequate, the 
body will begin to utilize omega-6 fatty acids as a replacement, which is associated with 
impaired or reduced visual and neurological function in animal models (Mulder et al., 
2018). The utilization of DHA in the body can be mediated by eicosapentaenoic acid 
(EPA), another omega-3 fatty acid (Greenberg et al., 2008). During pregnancy, EPA 
can help selectively transport DHA into fetal circulation and decreases the amount of 
circulating pro-inflammatory cytokines (Greenberg et al., 2008; Mozurkewich et al., 
2018). Pregnant women who are not consuming EPA along with DHA may limit the 
transport and uptake of DHA into fetal cells, making it extremely difficult to supply the 
fetus with the needed concentration of DHA to help support neurodevelopment 
(Greenberg et al., 2008). The impacts of improper DHA supplementation during 




deficits in psychomotor development, reading skills, visual acuity, problem solving, and 
attention in children (Rajarethnem et al., 2017). The lasting consequences of DHA 
under supplementation during gestation and commonly low amounts of omega-3 
consumption that is characteristic of the Western diet, calls for further studies to 
determine the mechanisms of DHA utilization during gestation and postnatally in 
human populations and the lasting effects of improper supplementation.  
Negative Affectivity  
When considering how nutritional intake and consumption during gestation 
relates to birth outcomes and early development of the infant, there is little literature 
exploring this relationship in human models. As previously stated, the role of specific 
supplements in neurodevelopment are well known, but their consequences on 
developmental outcomes of the fetus and infant are not well known, especially in cases 
of moderate deficiencies that are see in the United States. In non-human primate 
models, adult female macaques fed a Western-style diet throughout their pregnancy, 
similar to the American contemporary diet, had post-partum effects on the newborn’s 
developing regulatory system (Thompson et al., 2018). Specifically, negative behaviors 
of anxiety and fear (negative affectivity) in infants were associated with increased 
maternal adiposity and consumption of an inflammatory diet (Thompson et al., 2018). 
The proposed mechanism of this is that increased adipocyte mass causes the release of 
pro-inflammatory cytokines, increasing the overall in-utero inflammatory profile, 
altering fetal neurodevelopment in ways that influences long-term behavior and mood 
(Bilbo & Tsang, 2010). It has been demonstrated that a Western-style diet in non-




via increased reactive anxiety and defensive behaviors in response to fear and stress 
(Thompson et al., 2018). The potential capacity for the effect of a pro-inflammatory 
Western diet, increased adiposity, and improper supplementation to couple together to 
create adverse birth outcomes and impaired neurodevelopment could have potential 
long-lasting consequences for offspring in human models.  
This study aims to evaluate the influence of prenatal nutrition and 
supplementation, independently or in combination with increased maternal adiposity,  
on birth outcomes and levels of negative affectivity in 1-month old infants. I 
hypothesize that fetal exposure to a pro-inflammatory diet and increased adiposity 
during gestation will lead to more adverse birth outcomes (i.e. higher rates of cesarean 
deliveries, lower birth weights, smaller for gestational age, etc.) due to an increased in-
utero exposure to inflammation. I also hypothesize that improper supplementation and 
increased adiposity will lead to more adverse birth outcomes through the creation of 
nutritional deficiencies of key micronutrients during gestation. Additionally, I 
hypothesize that fetal exposure to a pro-inflammatory diet, improper supplementation, 
and increased adiposity during gestation leads to early indices of neurodevelopmental 
problems, such as higher levels of negative affect and regulatory problems in infants 1-
month post-partum.  
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300 pregnant women and their offspring were recruited for this study from 
Oregon Health & Science University’s (OHSU) prenatal clinics in the Portland 
metropolitan area, as well as other clinics in the greater Portland area who responded to 
PEACH Study recruitment materials. For my project, I have selected 55 participants 
from the larger sample due to their completion of all of the arms I am examining. 
Women recruited from OHSU clinics had their electronic medical records reviewed by 
study staff to determine if they were eligible for participation in the PEACH study. 
Participants that were recruited from OHSU clinics and non-OHSU sites were screened 
for eligibility by telephone. Upon consent, non-OHSU participants were asked to sign a 
HIPPA Authorization for Obtaining Existing Records Outside of OHSU form, giving 
PEACH Study Staff the ability to access and review the participant’s non-OHSU 
medical records. This study was approved by OHSU’s Institutional Review Board 
(#18579).  
Recruitment 
For women giving birth at OHSU, the names of pregnant patients were obtained 
from the OHSU electronic health record software called Epic. These records were 
reviewed for eligibility requirements and the recruiter called, and/or emailed eligible 
patients to invite them to participate in the study. When a woman indicated interest in 
participation, a further screening followed via telephone, or at the clinic if preferred, to 
describe the study in greater detail, determine final eligibility, and confirm interest.   
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Pregnant women aged 18-40, in good health, aside from increased BMI, were 
eligible for the study. Because BMI will be treated as a continuous risk factor for 
inflammation on development, we did not specifically recruit obese or overweight 
individuals. Instead, we monitored the sample to ensure that rates of obese or 
overweight individuals were consistent with national averages. Participants were pre-
screened and excluded if their pregnancies were deemed high risk due to multiple 
gestation, medical conditions (type 1 or 2 diabetes, mellitus, cancer, hypertension, 
kidney disease, and epilepsy), the presence of infection (HIV, hepatitis C), three 
miscarriages, or if the fetus had documented congenital anomalies or genetic conditions 
such as Down syndrome at chart review prior to recruitment outreach. At screening 
contact, expectant women were screened and exclude if they reported: smoking (> 5 
cigarettes during pregnancy), drinking alcohol (>10 drinks during pregnancy), 
marijuana use (currently legal in Oregon), and reported illicit drug use. Participants 
could also be excluded if they were enrolled in another study that involves an 
intervention. During the pregnancy follow-up period, women who develop gestational 
diabetes, preeclampsia, or test positive on a urine drug screen at either prenatal visit 
were excluded. Children born at less than 35 weeks were also excluded.  Once recruited 
and enrolled into the study, all participants were studied at OHSU.  
Consent Process 
If a woman qualified and agreed to participate, study staff asked her to sign the 
consent and authorization form, at either the screening visit or at her next prenatal visit. 




window of 22 weeks of pregnancy. The participant could also request to sign and return 
the consent and authorization form by mail and complete the informed consent over the 
phone. The consent process explained that participation remained voluntary, that 
families can withdraw at any point in the study without penalty, participation had no 
effect on eligibility for medical or clinical care, research information will be 
confidential, and that they would be informed regarding the limits of confidentiality. 
Confidentiality was limited due to a partial HIPPA Waiver that was submitted in order 
to collect protected health information during the phone screen such as: date of birth, 
sex, names, address, phone numbers, email address, medication status, primary 
household income, history of previous diagnoses and previous head injuries. This 
information was collected after receiving verbal consent over the phone and participants 
hold the right to not give the study their verbal consent and may refuse to answer any of 
the phone screen questions. All risks and benefits were clearly explained, and time was 
taken to clarify any questions that participants may have had. 
Compensation for Participation 
Participants were compensated for every measure they complete and could 
receive up to $550 for participating in the study. 
Prenatal Visit Schedule and Participant Activity 
Prenatal assessments occurred around the 22nd week of gestation and again 
around the 37th week of gestation, coinciding with their second and third trimesters of 
pregnancy. Visits occurred at OHSU and were scheduled according to the woman’s 
convenience.  A summary of the measures that I will be using for my project can be 





Figure 2: Summary of timing study measurements completed at participant visits and 
postnatally.  
Maternal Prenatal Measures  
 Maternal Body Composition (pre-pregnancy, 22 and 37 weeks gestation) 
Maternal body composition was measured at multiple time points. First, 
maternal pre-pregnancy weight was obtained from participants’ electronic medical 
records. During pregnancy, participants’ weight was measured again at 22 and 37 weeks 
of gestation. Weight was measured with a digital scale (Scale-Tronix, Model 5002), 
height with a Harpenden stadiometer, and skinfold thickness at the bicep, tricep, 
subscapular, and suprailiac areas was measured with a Lange caliper. Percent body fat, 
fat mass and lean mass was directly measured using air displacement plethysmography 
using a BodPod. The BodPod uses the Siri equation to calculate fat mass (FM) based on 
the weight and density measurements taken from the BodPod (van Raaij et al., 1989). 
An algorithm was developed by van Raaij, et al (1989) to account for alterations in fat 
mass hydration and density that occur during gestation and was used to alter the FM 




2nd Trimester Visit 
(22nd week of 
gestation):
• BodPod measures




3rd Trimester Visit 
(37th week of 
gestation):
• BodPod measures





























1W, weight (kg); D, body density (kg/m3).  
 
Maternal Prenatal Nutrition (22, 37 weeks gestation) 
At each time point, three unannounced 24-hour food recall phone interviews 
were conducted by trained nutritionists regarding food intake the day prior. The three 
interviews occur within two weeks of each time point (one weekend and two 
weekdays). All interviewers completed a training program and met qualification 
standards established in the OCTRI Bionutrition Unit using the Nutrition Data System 
for Research (NDSR) software (Nutrition Coordinating Center (NCC), University of 
Minnesota). The software facilitates the collection of recalls in a standardized fashion in 
a multiple-pass interview approach. The three recall days were averaged together for 
each time point for analysis. A Dietary Supplement questionnaire was completed to 
identify use of dietary supplements and non-prescription antacids.  
Dietary Inflammatory Index (DII)  
The DII was developed by researchers at the University of South Carolina to 
assess the inflammatory aspects of a diet and has been described in depth elsewhere. 




for associations between food components, or “parameters”, and specific inflammatory 
markers. Each article was given a score between 1 and -1 based on the effect of the food 
parameter on inflammation to create a database of 45 parameters. A score of +1 
indicates a maximally pro-inflammatory relationship, 0 indicates no significant 
relationship, and  -1 indicates a maximally anti-inflammatory relationship.  
Based on the data gathered from the 24 hour food recalls conducted at the 22nd 
and 37th week gestation visits, 30 food parameters (alcohol, vitamin B-12, vitamin B-6, 
β-carotene, caffeine, carbohydrate, cholesterol, energy, total fat, fiber, folic acid, iron, 
magnesium, mono-unsaturated fat, niacin, omega-3 fatty acids, omega-6 fatty acids, 
protein, poly-unsaturated fat, riboflavin, saturated fat, selenium, thiamin, trans-fat, 
vitamin A, vitamin C, vitamin D, vitamin E, and zinc) were selected and used for 
calculations. The individual dietary data of the participants was transformed into a z-
score by using the parameter specific global mean and standard deviation provided by 
the DII database. Since dietary data is often “right skewed”, the z-score was converted 
to a centered percentile score to minimize this effect. The centered percentile score was 
then multiplied by the respective inflammatory effect score to obtain the food parameter 
specific DII score. The individual food parameter scores were summed to calculate an 
overall DII score for every participant in the study at each of the visits and their scores 
for both trimesters were developed to generate an overall pregnancy average DII score. 
Measures After the Child is Born  
Medical records were reviewed to determine delivery health measures including 
delivery type, child gestational age, birth weight, gender, and perinatal complications. 




measures of birth weight for gestational age that were created using data from millions 
of US births to generate size percentiles (Oken et al., 2003). We obtained the 
Appearance, Pulse, Grimace, Activity, Respiration (APGAR) score to assess newborn 
health. 1 month after their baby’s birth, participants completed questionnaires asking 
about their infant’s behavior. Specifically, the Revised Infant Behavior Questionnaire 
(IBQ-R) was used to assess levels of negative affect in the infant. The IBQ-R is a 
widely used questionnaire that assess infant temperament along 14 different scales, such 
as smiling and laughter, activity level, fear, soothability, and cuddliness (Gartstein & 
Rothbart, 2003). Temperament is defined as the individual differences in reactivity (i.e. 
arousability of motor, emotional, and attentional response) and self-regulation 
(processes that regulate reactivity). To evaluate dysregulation in the infant, I examined 
the IBQ-R mean scores for negative affectivity and the categories used to calculate 
negative affectivity scores (Figure 3). Negative affectivity is calculated using total 
scores from the assessment of fear, distress to limitations, falling reactivity, and 
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Figure 3: IBQ-R calculation of negative affectivity in infants.  
After the IBQ-R is completed, negative affectivity is calculated using the means from 
the evaluations of fear, distress to limitations, falling reactivity, and sadness.  
Definitions provided from Enlow et al. (2016). 
Data Analysis  
SPSS version 27 software was used for all data analysis. Prior to analysis, 
categorical variables were coded in order to better analyze the data sets. An example of 
the coding of categorical variables can be found in Table 3. For all categorical variables 
that were  compared to quantitative data, one-way ANOVAs were used with an alpha of 
0.05 and confidence interval (CI) of 95%. If significance was found, a Tukey’s honestly 
significant difference (HSD) post hoc test was used to determine where the statistically 
significant difference occurred due to the multiple categories of the independent 
variables. When both the independent and dependent variables were categorical, a Chi2 









ity Fear: baby's distress or startle to sudden changes in stimulation, novel physical objects or social stimuli. 
Characterized by an inhibited response to novelty
Distress to Limitations: baby's fussing, crying or showing 
distress while confined in a place or position, unable to 
perform desired action, or while involved in caretaking 
activities. 
Falling Reactivity: rate of recovery from peak distress, 
excitement, or general arousal (i.e. ease of falling asleep) 
Sadness: general low mood or activity in relation to 
personal suffering, object loss, inability to preform a 




quantitative, a linear regression model was used with an alpha of 0.05 and confidence 
interval (CI) of 95%. 
Table 3. Example of how categorical variables were coded.  
Categorical Variable  Coding 








Overall, the average DII during pregnancy in this sample was -0.92 ± 1.34 with 
a range of -3.45 to 2.08. There was no statistically significant relationship between BMI 
and FM during the 2nd and 3rd trimester and DII score (p>0.05). Maternal participant 
characteristics and demographics can be found in Table 4. A higher level of maternal 
education was associated with lower DII scores (more anti-inflammatory) for the 2nd 
trimester (F(4,50) = 3.225, p=0.02) and their pregnancy average score (F(4,50)=2.641, 
p=0.044).  
Table 4: Maternal participant characteristics according to pregnancy average DII in 
quartiles.  
  DII Quartile (Pregnancy Average) 
 Total (n = 55) Q1 (n = 14) Q2 (n = 13) Q3 (n = 14) Q4 (n = 14) 
Pregnancy average 
DII 
-0.92 ± 1.34  -2.45 ± 0.50 -1.49 ± 0.32 -0.70 ± 0.32 0.91 ± 0.72 
DII range -3.45, 2.08     
Age at enrollment  32.79 ± 4.15  34.24 ± 2.84 30.95 ± 3.61 33.14 ± 4.31 32.70 ± 5.22 
2nd trimester BMI 
category, kg/m2  
     
18.5 to <25 21 (38%) 5 (36%) 6 (46%) 4 (28%) 6 (43%) 
25 to <30 25 (45%) 5 (36%) 6 (46%) 5 (36%) 7 (50%) 
≥30 9 (16%) 4 (28%) 1 (8%) 5 (36%) 1 (7%) 
3rd trimester BMI 
category, kg/m2 
     
18.5 to <25 11 (20%) 2 (14%) 5 (38%) 1 (7%) 3 (21%) 
25 to <30  31 (56%) 7 (50%) 7 (54%) 8 (57%) 9 (64%) 
≥30 13 (24%) 5 (36%) 1 (8%) 5 (36%) 2 (15%) 
Highest Level of 
Maternal Education  
     
Some College 5 (9.1%) 0 1 (7.7%) 1 (7.1%) 3 (21%) 
Associates Degree 3 (5.5%) 1 (7.1%) 0 0 2 (14%) 
Bachelor’s Degree 26 (47%) 9 (64%) 7 (54%) 6 (43%) 4 (28%) 
Graduate Degree 20 (36%) 4 (28%) 5 (38%) 7 (50%) 4 (28%) 
Doctorate  1 (1.8%) 0 0 0 1 (7.1%) 
Marital Status       
Never Married  7 (13%) 2 (14%) 1 (7.7%) 2 (14%) 2 (14%) 
Married  48 (87%) 12 (86%) 12 (92%) 12 (86%) 12 (86%) 
Household Income      
<$25,000 1 (1.8%) 0 0 1 (7.1%) 0 
$25,000-$49,999 3 (5.5%) 1 (7.1%) 0 0 2 (14%) 
$50,000-$100,000 19 (34%) 6 (43%) 7 (54%) 2 (14%) 4 (28%) 
>$100,000 32 (58%) 7 (50%) 6 (46%) 11 (78%) 8 (57%) 
Maternal Ethnicity       




Non-Hispanic  53 (96%) 14 (100%) 13 (100%) 14 (100%) 12 (86%) 
Maternal Race      
American Indian/ 
Alaska Native  
3 (5.1%) 1 (7.1%) 0 1(7.1%) 1 (6.6%) 
Asian/East Indian 3 (5.1%) 0 2 (14%) 1 (7.1%) 0 
Black/African 
American 
1 (1.7%) 1 (7.1%) 0 0 0 
White/Middle 
Eastern 
51 (88%) 12 (86%) 13 (86%) 12 (86%) 14 (93%) 
Method of delivery       
Vaginal  35 (64%) 7 (50%) 11 (85%) 7 (50%) 10 (71%) 
Cesarean  20 (36%) 7 (50%) 2 (15%) 7 (50%) 4 (29%) 
Data presented are means ± standard deviations (SDs) or n (%).Q, quartile. A BMI of 
18.5 to less than 25 is considered normal, 25 to less than 30 is overweight, and 30 or 
greater is considered obese. Data is presented in quartiles only for visualization and 
analysis was conducted using the total (n = 55) sample.  
Infant characteristic and demographics can be found in table 5. There was a 
statistically significant relationship between birth length and infant sex (F(1,53) = 
4.388, p=0.041), where males had significantly larger birth lengths (51.67 ± 1.92) than 
females (50.52 ± 2.03).  
 
Table 5: Infant characteristics and demographics according to pregnancy average DII 
quartiles.  
  DII Quartile (Pregnancy Average) 
 Total (n = 55) Q1 (n = 14) Q2 (n = 13) Q3 (n = 14) Q4 (n = 14) 
Child Ethnicity       
Hispanic  2 (4%) 0 1 (8%) 0 2 (14%) 
Non-Hispanic  53 (96%) 14 (100%) 12 (92%) 14 (100%) 12 (86%) 
Child Race      
American Indian/ 
Alaska Native  
2 (3.3%) 0 0 1 (7%) 1 (5.8%) 
Asian/East Indian 6 (10% 1 (7%) 3 (20%) 1 (7%) 1 (5.8%) 
Black/African 
American 
2 (3.3%) 1 (7%) 0 0 1 (5.8%) 
White/Middle Eastern 50 (83%) 12 (86%) 12 (80%) 12 (86%) 14 (82%) 
Birthweight (kg) 3.44 ± 0.42 3.44 ± 0.43 3.38 ± 0.34 3.39 ± 0.54 3.53 ± 0.39 
Discharge weight (kg) 3.26 ± 0.40 3.24 ± 0.40 3.22 ± 0.37 3.21 ± 0.49 3.38 ± 0.36 
GA, wk  39.6 ± 1.1 39.86 ± 0.83 39.55 ± 1.12 39.59 ± 1.38 39.41 ± 1.06 
BW/GA category       
SGA 3 (5.5%) 1 (7%) 1 (8%) 1 (7%) 0 
AGA 49 (89%) 12 (86%) 12 (92%) 12 (86%) 13 (93%) 
LGA 3 (5.5%) 1 (7%) 0 1 (7%) 1 (7%) 






34.62 ± 1.56 34.31 ± 0.84 34.55 ± 2.46 34.43 ± 1.57 35.16 ± 0.94 
Infant Sex       
Female  33 (60%) 9 (64%) 9 (69%) 8 (57%) 7 (50%) 
Male  22 (40%) 5 (36%) 4 (31%) 6 (43%) 7 (50%) 
APGAR at 1 minute  7.93 ± 1.67 7.07 ± 5.23 8.31 ± 0.63 8.21 ± 1.05 8.14 ± 1.61 
APGAR at 5 minutes 8.87 ± 0.64 8.71 ± 1.14  8.85 ± 0.38 8.86 ± 0.36 9.07 ± 0.27 
1-month IBQ Scores      
NA 3.01 ± 0.59 3.25 ± 0.57 2.82 ± 0.55 3.12 ± 0.55 2.84 ± 0.65 
Sadness mean  3.04 ± 1.1 3.45 ± 1.22 2.69 ± 0.76 3.24 ± 1.16 2.74 ± 0.93 
Distress to limitations 
mean  
3.9 ± 0.92 4.16 ± 0.74 3.92 ± 0.98 3.94 ± 1.05 3.58 ± 0.88 
Fear mean  1.96 ± 0.74 1.99 ± 0.72 1.74 ± 0.38 1.99 ± 0.86 2.09 ± 0.91 
Falling reactivity mean  4.85 ± 0.97 4.60 ± 0.89 5.08 ± 0.88 4.68 ± 1.11 5.04 ± 0.97 
Data presented are means ± standard deviations (SDs) or n (%). GA, gestational age; 
BW/GA, birthweight for gestational age; SGA, small for gestational age; AGA, average 
for gestational age; LGA, large gestational age; NA, negative affectivity; Q, quartile. 
Data is presented in quartiles only for visualization and analysis was conducted using 
the total (n = 55) sample.  
DII and Birth Outcomes  
There was a statistically significant association between 3rd trimester DII and 5-
minute APGAR score (β=0.327, r=0.327, p=0.015), where an increase in DII score 
(more pro-inflammatory) was associated with a higher APGAR score. This association 
was also seen between pregnancy average DII and 5-minute APGAR score (β=0.276, 
r=0.276, p=0.041). There were no statistically significant association between the DII 
and any other birth outcomes examined (Table 6).  
Table 6: Significant results from linear regression for DII scores and birth outcomes. 





3T DII  APGAR at 5-min 0.327 0.069 0.015 
Pregnancy Average 
DII  
APGAR at 5-min 0.276 0.063 0.041 
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Supplement Usage  
The supplement usage characteristics of our sample for both the 2nd and 3rd 
trimesters can be found in Table 7. In our sample, there were 55 different prenatal 
supplements and multivitamins taken over the duration of participants pregnancy. In the 
2nd trimester an average of 2.97 ± 1.73 different supplements were taken and in the 3rd 
trimester an average of 3.09 ± 1.51 supplements were taken, both with a range of 1 to 8. 
Four participants were taking two different prenatal vitamins at the same time in the 2nd 
trimester.  
Table 7: Supplement characteristics during the 2nd and 3rd trimester.  
Micronutrient  2nd Trimester (n = 55) 3rd Trimester (n = 55) 
DHA + EPA    
Under 41 (75%) 29 (53%) 
Over 14 (25%) 15 (27%) 
DHA   
Under 28 (51%) 29 (53%) 
Over 15 (27%) 15 (27%) 
Proper 12 (22%) 11 (20%) 
Choline   
Under  55 (100%) 55 (100%) 
Thiamine    
Under  14 (25%) 17 (31%) 
Over  31 (56%) 26 (47%) 
Proper   10 (18%) 12 (22%) 
Vitamin B6   
Under  4 (7.3%) 6 (11%)  
Over  43 (78%) 38 (69%) 
Proper  8 (15%) 11 (20%) 
Folic Acid    
Under  28 (51%) 33 (60%) 
Over  5 (9.1%)  4 (7.3%) 
Proper  22 (40%) 18 (33%) 
Vitamin B12   
Under  2 (3.6%) 3 (5.5%) 
Over  53 (96%) 52 (95%) 
Iodine   
Under  40 (73%) 38 (69%) 
Over  7 (13%) 7 (13%) 
Proper  8 (15%) 10 (18%) 
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Prenatal    
Yes  54 (98%) 54 (98%) 
No 1 (2%) 1 (2%) 
Values are reported in n (%).  
Supplement Usage and Birth Outcomes  
There was a statistically significant association between 2nd trimester DHA and 
EPA supplementation and the APGAR score at 5 minutes (F(1,53) = 7.091, p=0.01). 
Specifically, under supplementation of DHA and EPA is associated with a higher mean 
APGAR score (9 ± 0.316) than over supplementation (8.5 ± 1.09). This association was 
also observed between 3rd trimester DHA and EPA supplementation and the APGAR 
score at 5 minutes (F(1,53) = 4.429, p=0.04).  
There was also a statistically significant association between 2nd trimester 
iodine supplementation and the APGAR score at 5 minutes (F(2,52) = 3.740, p=0.03). 
Specifically, over-supplementation is associated with higher APGAR scores (8.95 ± 
0.389), while  under-supplementation is associated with lower APGAR scores (8.29 ± 
1.496). Post hoc testing demonstrated that the means from the under-supplementation 
group was statistically significantly different from the over supplementation group 
(p=0.028). Similarly, this association was also seen between the 3rd trimester iodine 
supplementation and 5-minute APGAR scores (F(2,52) = 3.748, p=0.03). However, 
over-supplementation is associated with lower APGAR scores (8.29 ± 1.496), while  
under-supplementation is associated with higher APGAR scores (8.95 ± 0.399). Post 
hoc testing demonstrated that the means from the under-supplementation group were 
statistically significantly different from the over supplementation group (p=0.029).  
There were no statistically significant results between the other micronutrients 




DII and IBQ-R 
There were no significant associations between the DII and the IBQ-R 
categories examined (p>0.05).  
Supplement Usage and IBQ-R  
There was a statistically significant association between 3rd trimester folic acid 
supplementation and NA means (F(2,52) = 4.871, p=0.012) (Figure 4). Specifically, 
under supplementation is associated with lower NA means (2.82 ± 0.515) than proper 
supplementation (3.27 ± 0.62). Post hoc testing demonstrated that the means from the 
under-supplementation group were statistically significantly different from the proper 





Figure 4: Levels of negative affect (NA) in 1-month infants and folic acid 
supplementation during the 3rd trimester.  
Proper supplementation of folic acid (between 400-800 mcg/day) was significantly 
associated with greater levels of NA in infants, while under-supplementation was 
significantly associated with lower levels of NA. * indicates the statistically significant 
relationships within the levels of folic acid supplementation.  
There were no other significant relationships between the micronutrients 






The goal of the current study was to examine whether poor maternal nutrition, in 
combination with or independent of adiposity, predict more adverse birth outcomes and 
higher levels of negative affect and regulatory problems in infants 1-month post-partum. 
Though the effects of maternal adiposity and dietary inflammatory potential have been 
examined in relation to birth outcomes in previous studies, this study’s inclusion of 
supplement usage and infant regulatory behavior will expand the current literature 
surrounding maternal factors that influence child outcomes and development. Results 
from my analysis suggest that certain micronutrient supplementation is associated with 
higher APGAR scores at 5-minutes. Specifically, decreased DHA and EPA 
supplementation in the 2nd and 3rd  trimesters, increased iodine supplementation in the 
second trimester, and decreased Iodine supplementation in the 3rd trimester is all 
associated with higher APGAR scores at 5-minutes. Additionally, an increase in 3rd 
trimester and pregnancy average DII scores (i.e. more pro-inflammatory) is associated 
with higher APGAR scores at 5-minutes.  
Even though the APGAR score is a widely used instrument for reporting 
newborn health, it does have limitations and numerous factors that can influence 
scoring. Assessing the physiological health of an infant at one point in time includes 
subjective observation and factors like maternal sedation, gestational age, and 
interobserver variability can influence the scores given (The Apgar Score, n.d.). An 
APGAR score between 7-10 at 5 minutes is indicative of good health at birth and our 
sample’s score ranged from 5-10 with an average of 8.87. Due to our sample being 




reduction of dietary inflammation will drastically improve APGAR scores at 5-minutes. 
The APGAR score is still a meaningful method for assessing newborn health, but 
specifically for preterm and term infants with very low scores (0-3), which was not seen 
in our sample (Casey et al., 2001). It is known that newborns with increased gestational 
age and size is associated with higher APGAR scores; however, these were not 
predictive in our sample (Behnke et al., 1987).  
Interestingly, we did not see any associations between the other birth outcomes 
examined and maternal diet and adiposity. As the prior research regarding the DII’s 
influence on birth outcomes is relatively limited, the association between the DII and 
maternal and birth outcomes is an evolving field of research. Previous studies have 
found that the consumption of a pro-inflammatory diet is associated with elevated rates 
of caesarean delivery in women with BMI’s > 25 kg/m2 and decreased fetal growth 
(McCullough et al., 2017; Sen et al., 2016). Even though we were not able to replicate 
these findings in our sample, our novel finding suggesting that higher 5-minute APGAR 
scores were associated with more pro-inflammatory diets warrants further research with 
a larger and more diverse sample to determine if this association is still significant.  
It is well known that an increase in maternal adiposity is associated with more 
adverse birth outcomes for both the mother and child (King, 2006). However, our study 
found no association between BMI or measured fat mass in the 2nd and 3rd trimesters 
and birth outcomes. Data has shown that increased adiposity causes chronic, low-grade 
inflammation due to the secretion of pro-inflammatory cytokines in adipose tissues that 
create harmful conditions to the fetus and pre-dispose mothers with obesity to more 
birth complications (Catalano & Shankar, 2017). This contrasting result may be 
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attributed to the small sample size of this study resulting in a lower statistical power that 
limited our ability to detect this association in our sample.  
Finally, my analyses suggest that increased folic acid supplementation is 
associated with higher levels of negative affect in infants 1-month post-partum. During 
pregnancy, folic acid is supplemented to support general growth and development of the 
fetus and is preventative against NTD’s. The association between supplementation and 
infant temperament could demonstrate that infants that received proper supplementation 
may have greater engagement and sensitivity to their environment than those who did 
not receive proper supplementation. Even though use of the IBQ-R for infants as young 
as 2 weeks of age has shown to have reliability, convergent validity, and relative 
stability, it is most commonly used to assess infants starting 2 months of age into early 
childhood (Gartstein & Rothbart, 2003). Starting at 2 months old, caregivers are able to 
more reliably observe temperament, especially positive emotionality (Rothbart, 1989). 
Since we used the IBQ-R to assess infant temperament prior to this time period, we 
could have gotten higher ratings of negative emotionality (i.e. negative affect, fear, etc.) 
due to decreased expression of positive emotionality, as it is rarely expressed in the 
newborn period. 
One of the most interesting results of this study is the extreme amount of 
variability and improper supplementation among our sample. There was 55 different 
prenatal supplements and multivitamins taken over the duration of participants 
pregnancies. Of these supplements, the most common was Prenatal Multi Plus DHA by 
Nature Made, which improperly supplements on half of micronutrients examined in this 




supplemented all of the micronutrients, even the prescription prenatal vitamins. 
Additionally, none of the supplements met the recommended choline supplementation. 
Baby and Me 2 by MegaFood and Full Circle Prenatal were the prenatal supplements 
that had the choline dosage closest to the recommended value, but remained 150 mg 
below adequate supplementation. 
Table 8: Comparison of recommended micronutrient supplementation to Prenatal Multi 
Plus DHA by Nature Made ingredients.  
 Recommended  Prenatal Multi Plus DHA 
Iodine  220 mcg  150 mcg  
Choline 450 mg 0 mg  
B6 1.9 mg 1.9 mg 
B12 2.6 mcg 5.2 mcg 
Folic Acid 400-800 mcg 800 mcg 
Thiamine (B-1) 1.4 mg  1.4 mg  
DHA 200 mg 200 mg 
DHA+EPA  300 mg  260 mg 
 
As the American diet is changing substantially towards more processed, less 
nutrient-rich food, it is vital that women are properly supplementing these nutrients, as 
they will likely not obtain these nutrients from their diet alone. The supplement industry 
is still widely unregulated, leaving the consumer to decipher supplement labels and trust 
that these companies are using high quality ingredients that are bioavailable. However, 
as this study shows, this is extremely problematic. The recommended supplementation 




widely known, yet out of the 55 participants in this study, not one was able to 
completely properly supplement all of the micronutrients examined. As research has 
shown, improper supplementation during this time period can lead to permanent 
developmental and growth consequences. Consumers should be assured that every 
prenatal can adequately meet this nutritional demand at an affordable price.  
Limitations 
 This study is limited by a relatively small, homogenous sample that restricted 
our ability to draw conclusions with high statistical power. Part of our exclusion criteria 
eliminates participants with higher risk pregnancies, like those with preeclampsia, that 
limits the variability of our sample. Also, the use of nutrition recalls and supplement 
questionnaires are inherently error prone as they rely on participant’s memory in an 
uncontrolled environment. Additionally, we were unable to correlate the DII with 
circulating pro-inflammatory cytokine concentrations. It is still relatively unknown how 
accurate the DII is in pregnant populations, but it is well established in normal adult 
populations. Being able to correlate reported dietary inflammatory potential with 
biological markers would strengthen the use of the DII as an assessment tool in 
pregnant populations. Lastly, the Covid-19 pandemic has introduced several limitations 
to human subject’s research. As this data is part of a larger, ongoing research study, the 
participants used in this project were limited due to the inability to have in-person visits 
that provide data for body composition measurements.  
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This study provides an assessment of dietary inflammation and supplementation 
in relation to birth outcomes and emotional dysregulation of 1-month old infants, with 
consideration of maternal adiposity. Our results suggests that diet and supplementation 
may not only impact birth outcomes, but also infant temperament. We have used the DII 
and supplementation as a means to assess emotional dysregulation in infants in a novel 
way, finding an association between folic acid supplementation and negative affectivity 
in infants. Also, we have illustrated the immense variability and inadequacy of prenatal 
vitamins and the need to regulate the supplement industry to ensure that they are 
meeting well known nutritional recommendations during a time of crucial fetal 
development and growth.  
Future studies may seek to understand how the DII is associated with circulating 
pro-inflammatory cytokines in pregnant populations and seek the mechanisms linking 
inflammation to birth outcomes and infant behavior. Also, studies should use the IBQ-R 
longitudinally to assess child and infant behavior in relation to DII scores and 
supplementation in pregnancy to see how poor nutrition impacts child growth and 
development over time. Lastly, the influence of poor maternal nutrition should be 
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Infant Behavior Questionnaire-Revised    
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Subject No. _______________   Date of Baby’s Birth ______  ____  
_____ 
           month.   day     
year 
Today’s Date _______________   Age of Child  _____  _____ 
           mos.    weeks 





Please read carefully before starting: 
 
As you read each description of the baby’s behavior below, please indicate how often 
the baby did this during the LAST WEEK (the past seven days) by circling one of the 
numbers in the left column.  These numbers indicate how often you observed the 































The “Does Not Apply” (X) column is used when you did not see the baby in the 
situation described during the last week.  For example, if the situation mentions the 
baby having to wait for food or liquids and there was no time during the last week when 
the baby had to wait, circle the (X) column. “Does Not Apply” is different from 
“Never” (1).  “Never” is used when you saw the baby in the situation but the baby never 
engaged in the behavior listed during the last week.  For example, if the baby did have 
to wait for food or liquids at least once but never cried loudly while waiting, circle the 
(1) column. 
 






During feeding, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (1) lie or sit quietly? 
1   2   3   4   5   6   7   X . . . . (2) squirm or kick? 
1   2   3   4   5   6   7   X . . . . (3) wave arms? 
1   2   3   4   5   6   7   X . . . . (4) notice lumpy texture in food (e.g., oatmeal)? 
 
In the last week, while being fed in your lap, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (5) seem to enjoy the closeness? 
1   2   3   4   5   6   7   X . . . . (6) snuggle even after she was done? 
1   2   3   4   5   6   7   X . . . . (7) seem eager to get away as soon as the feeding was 
over? 
 
How often did your baby make talking sounds: 
1   2   3   4   5   6   7   X . . . . (8) while waiting in a high chair for food? 
1   2   3   4   5   6   7   X . . . . (9) when s/he was ready for more food? 





Before falling asleep at night during the last week, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (11) show no fussing or crying? 
 
During sleep, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (12) toss about in the crib? 
1   2   3   4   5   6   7   X . . . . (13) move from the middle to the end of the crib? 
1   2   3   4   5   6   7   X . . . . (14) sleep in one position only? 
 
After sleeping, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (15) fuss or cry immediately? 




1   2   3   4   5   6   7   X . . . . (17) cry if someone doesn’t come within a few minutes?  
 
How often did the baby: 
1   2   3   4   5   6   7   X . . . . (18) seem angry (crying and fussing) when you left 
                                                      her/him in the crib? 
1   2   3   4   5   6   7   X . . . . (19) seem contented when left in the crib? 
1   2   3   4   5   6   7   X . . . . (20) cry or fuss before going to sleep for naps? 
 
When going to sleep at night, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (21) fall asleep within 10 minutes? 
1   2   3   4   5   6   7   X . . . . (22) have a hard time settling down to sleep? 
1   2   3   4   5   6   7   X . . . . (23) settle down to sleep easily? 
 
 
When your baby awoke at night, how often did s/he: 
1   2   3   4   5   6   7   X . . . . (24) have a hard time going back to sleep? 
1   2   3   4   5   6   7   X . . . . (25) go back to sleep immediately? 
 
When put down for a nap, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (26) stay awake for a long time? 
1   2   3   4   5   6   7   X . . . . (27) go to sleep immediately? 
1   2   3   4   5   6   7   X . . . . (28) settle down quickly? 
1   2   3   4   5   6   7   X . . . . (29) have a hard time settling down? 
 
When it was time for bed or a nap and your baby did not want to go, how often did s/he: 
1   2   3   4   5   6   7   X . . . . (30) whimper or sob? 
1   2   3   4   5   6   7   X . . . . (31) become tearful? 
 
 
Bathing and Dressing 
 
When being dressed or undressed during the last week, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (32) wave her/his arms and kick? 
1   2   3   4   5   6   7   X . . . . (33) squirm and/or try to roll away? 
1   2   3   4   5   6   7   X . . . . (34) smile or laugh? 
1   2   3   4   5   6   7   X . . . . (35) coo or vocalize? 
 
When put into the bath water, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (36) smile? 
1   2   3   4   5   6   7   X . . . . (37) laugh? 
1   2   3   4   5   6   7   X . . . . (38) splash or kick? 
1   2   3   4   5   6   7   X . . . . (39) turn body and/or squirm? 
 
When face was washed, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (40) smile or laugh? 




1   2   3   4   5   6   7   X . . . . (42) coo? 
 
When hair was washed, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (43) smile? 
1   2   3   4   5   6   7   X . . . . (44) fuss or cry? 





How often during the last week did the baby: 
1   2   3   4   5   6   7   X . . . . (46) look at pictures in books and/or magazines for 
                                                      2-5 minutes at a time? 
1   2   3   4   5   6   7   X . . . . (47) look at pictures in books and/or magazines for 
                                                      5 minutes or longer at a time? 
1   2   3   4   5   6   7   X . . . . (48) stare at a mobile, crib bumper or picture for 
                                                      5 minutes or longer? 
1   2   3   4   5   6   7   X . . . . (49) play with one toy or object for 5-10 minutes? 
1   2   3   4   5   6   7   X . . . . (50) play with one toy or object for 10 minutes or longer? 
1   2   3   4   5   6   7   X . . . . (51) spend time just looking at playthings? 
1   2   3   4   5   6   7   X . . . . (52) repeat the same sounds over and over again? 
1   2   3   4   5   6   7   X . . . . (53) laugh aloud in play? 
1   2   3   4   5   6   7   X . . . . (54) repeat the same movement with an object for 2 
      minutes or longer (e.g., putting a block in a cup, kicking 
      or hitting a mobile)? 
1   2   3   4   5   6   7   X . . . . (55) pay attention to your reading during most of the story 
      when looking at picture books? 
1   2   3   4   5   6   7   X . . . . (56) smile or laugh after accomplishing something (e.g.,  
      stacking blocks, etc.)? 
1   2   3   4   5   6   7   X . . . . (57) smile or laugh when given a toy? 
1   2   3   4   5   6   7   X . . . . (58) smile or laugh when tickled? 
 
How often during the last week did the baby enjoy: 
1   2   3   4   5   6   7   X . . . . (59) being sung to? 
1   2   3   4   5   6   7   X . . . . (60) being read to? 
1   2   3   4   5   6   7   X . . . . (61) hearing the sound of words, as in nursery rhymes? 
1   2   3   4   5   6   7   X . . . . (62) looking at picture books? 
1   2   3   4   5   6   7   X . . . . (63) gentle rhythmic activities, such as rocking or 
swaying? 
1   2   3   4   5   6   7   X . . . . (64) lying quietly and examining his/her fingers or toes? 
1   2   3   4   5   6   7   X . . . . (65) being tickled by you or someone else in your family? 
1   2   3   4   5   6   7   X . . . . (66) being involved in rambunctious play? 
1   2   3   4   5   6   7   X . . . . (67) watching while you, or another adult, playfully   
       made faces? 
1   2   3   4   5   6   7   X . . . . (68) touching or lying next to stuffed animals? 




1   2   3   4   5   6   7   X . . . . (70) being rolled up in a warm blanket? 
1   2   3   4   5   6   7   X . . . . (71) listening to a musical toy in a crib? 
 
When playing quietly with one of her/his favorite toys, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (72) show pleasure? 
1   2   3   4   5   6   7   X . . . . (73) enjoy lying in the crib for more than 5 minutes? 
1   2   3   4   5   6   7   X . . . . (74) enjoy lying in the crib for more than 10 minutes? 
 
When something the baby was playing with had to be removed, how often did s/he: 
1   2   3   4   5   6   7   X . . . . (75) cry or show distress for a time? 
1   2   3   4   5   6   7   X . . . . (76) seem not bothered? 
 
When tossed around playfully how often did the baby: 
1   2   3   4   5   6   7   X . . . . (77) smile? 
1   2   3   4   5   6   7   X . . . . (78) laugh? 
 
During a peekaboo game, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (79) smile? 
1   2   3   4   5   6   7   X . . . . (80) laugh? 
 
How often did your baby enjoy bouncing up and down: 
1   2   3   4   5   6   7   X . . . . (81) while on your lap? 
1   2   3   4   5   6   7   X . . . . (82) on an object, such as a bed, bouncer chair, or toy? 
 
How often did the infant look up from playing: 
1   2   3   4   5   6   7   X . . . . (83) when the telephone rang? 
1   2   3   4   5   6   7   X . . . . (84) when s/he heard voices in the next room? 
 
When your baby saw a toy s/he wanted, how often did s/he:  
1   2   3   4   5   6   7   X . . . . (85) get very excited about getting it? 
1   2   3   4   5   6   7   X . . . . (86) immediately go after it? 
 
When given a new toy, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (87) get very excited about getting it? 
1   2   3   4   5   6   7   X . . . . (88) immediately go after it? 




How often during the last week did the baby: 
1   2   3   4   5   6   7   X . . . . (90) cry or show distress at a change in parents’ 
      appearance, (glasses off, shower cap on, etc.)? 
1   2   3   4   5   6   7   X . . . . (91) when in a position to see the television set, 






How often during the last week did the baby: 
1   2   3   4   5   6   7   X . . . . (92) when in a position to see the television set, 
      look at it for 5 minutes or longer? 
1   2   3   4   5   6   7   X . . . . (93) protest being placed in a confining place (infant 
      seat, play pen, car seat, etc)? 
1   2   3   4   5   6   7   X . . . . (94) startle at a sudden change in body position (for 
      example, when moved suddenly)? 
1   2   3   4   5   6   7   X . . . . (95) appear to listen to even very quiet sounds? 
1   2   3   4   5   6   7   X . . . . (96) attend to sights or sounds when outdoors (for 
example, wind 
      chimes or water sprinklers)? 
1   2   3   4   5   6   7   X . . . . (97) move quickly toward new objects? 
1   2   3   4   5   6   7   X . . . . (98) show a strong desire for something s/he wanted? 
1   2   3   4   5   6   7   X . . . . (99) startle to a loud or sudden noise? 
1   2   3   4   5   6   7   X . . . . (100) look at children playing in the park or on the 
        playground for 5 minutes or longer? 
1   2   3   4   5   6   7   X . . . . (101) watch adults performing household activities 
         (e.g., cooking, etc.) for more than 5 minutes? 
1   2   3   4   5   6   7   X . . . . (102) squeal or shout when excited? 
1   2   3   4   5   6   7   X . . . . (103) imitate the sounds you made? 
1   2   3   4   5   6   7   X . . . . (104) seem excited when you or other adults acted in an 
        excited manner around him/her? 
 
When being held, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (105) pull away or kick? 
1   2   3   4   5   6   7   X . . . . (106) seem to enjoy him/herself? 
1   2   3   4   5   6   7   X . . . . (107) mold to your body? 
1   2   3   4   5   6   7   X . . . . (108) squirm? 
 
When placed on his/her back, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (109) fuss or protest? 
1   2   3   4   5   6   7   X . . . . (110) smile or laugh? 
1   2   3   4   5   6   7   X . . . . (111) wave arms and kick? 
1   2   3   4   5   6   7   X . . . . (112) squirm and/or turn body? 
 
When the baby wanted something, how often did s/he: 
1   2   3   4   5   6   7   X . . . . (113) become upset when s/he could not get what s/he 
wanted? 
1   2   3   4   5   6   7   X . . . . (114) have tantrums (crying, screaming, face red, etc.) 
        when s/he did not get what s/he wanted? 
 
When placed in an infant seat or car seat, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (115) wave arms and kick? 
1   2   3   4   5   6   7   X . . . . (116) squirm and turn body? 
1   2   3   4   5   6   7   X . . . . (117) lie or sit quietly? 




When frustrated with something, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (119) calm down within 5 minutes? 
 
When your baby was upset about something, how often did s/he: 
1   2   3   4   5   6   7   X . . . . (120) stay upset for up to 10 minutes or longer? 
1   2   3   4   5   6   7   X . . . . (121) stay upset for up to 20 minutes or longer? 
1   2   3   4   5   6   7   X . . . . (122) soothe her/himself with other things (such as a 
stuffed 
        animal, or blanket)? 
 
When rocked or hugged, in the last week, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (123) seem to enjoy her/himself? 
1   2   3   4   5   6   7   X . . . . (124) seemed eager to get away? 
1   2   3   4   5   6   7   X . . . . (125) make protesting noises? 
 
When reuniting after having been away during the last week how often did the baby: 
1   2   3   4   5   6   7   X . . . . (126) seem to enjoy being held? 
1   2   3   4   5   6   7   X . . . . (127) show interest in being close, but resisted being held? 
1   2   3   4   5   6   7   X . . . . (128) show distress at being held? 
 
When being carried, in the last week, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (129) seem to enjoy him/herself? 
1   2   3   4   5   6   7   X . . . . (130) push against you until put down? 
 
While sitting in your lap: 
1   2   3   4   5   6   7   X . . . . (131) how often did your baby seem to enjoy her/himself? 
1   2   3   4   5   6   7   X . . . . (132) how often would the baby not be content without 
moving around? 
 
How often did your baby notice: 
1   2   3   4   5   6   7   X . . . . (133) low-pitched noises, air conditioner, heating system, 
or  
        refrigerator running or starting up? 
1   2   3   4   5   6   7   X . . . . (134) sirens from fire trucks or ambulances at a distance? 
1   2   3   4   5   6   7   X . . . . (135) a change in room temperature? 
1   2   3   4   5   6   7   X . . . . (136) a change in light when a cloud passed over the sun? 
1   2   3   4   5   6   7   X . . . . (137) sound of an airplane passing overhead? 
1   2   3   4   5   6   7   X . . . . (138) a bird or a squirrel up in a tree? 
1   2   3   4   5   6   7   X . . . . (139) fabrics with scratchy texture (e.g., wool)? 
 
When tired, how often was your baby: 
1   2   3   4   5   6   7   X . . . . (140) likely to cry? 
1   2   3   4   5   6   7   X . . . . (141) show distress? 
 
At the end of an exciting day, how often did your baby: 




1   2   3   4   5   6   7   X . . . . (143) show distress? 
 
For no apparent reason, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (144) appear sad? 
1   2   3   4   5   6   7   X . . . . (145) seem unresponsive?  
 
How often did your baby make talking sounds when: 
1   2   3   4   5   6   7   X . . . . (146) riding in a car? 
1   2   3   4   5   6   7   X . . . . (147) riding in a shopping cart? 
1   2   3   4   5   6   7   X . . . . (148) you talked to her/him? 
 
Two Week Time Span 
 
When you returned from having been away and the baby was awake, how often did 
s/he: 
1   2   3   4   5   6   7   X . . . . (149) smile or laugh? 
 
When introduced to an unfamiliar adult, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (150) cling to a parent? 
1   2   3   4   5   6   7   X . . . . (151) refuse to go to the unfamiliar person? 
1   2   3   4   5   6   7   X . . . . (152) hang back from the adult? 
1   2   3   4   5   6   7   X . . . . (153) never “warm up” to the unfamiliar adult? 
 
When in the presence of several unfamiliar adults, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (154) cling to a parent? 
1   2   3   4   5   6   7   X . . . . (155) cry? 
1   2   3   4   5   6   7   X . . . . (156) continue to be upset for 10 minutes or longer? 
 
When visiting a new place, how often did the baby: 
1   2   3   4   5   6   7   X . . . . (157) show distress for the first few minutes? 
1   2   3   4   5   6   7   X . . . . (158) continue to be upset for 10 minutes or more? 
1   2   3   4   5   6   7   X . . . . (159) get excited about exploring new surroundings? 
1   2   3   4   5   6   7   X . . . . (160) move about actively when s/he is exploring new 
        surroundings? 
 
When your baby was approached by an unfamiliar person when you and s/he were out 
(for example, shopping), how often did the baby: 
1   2   3   4   5   6   7   X . . . . (161)  show distress? 
1   2   3   4   5   6   7   X . . . . (162)  cry? 
 
When an unfamiliar adult came to your home or apartment, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (163) allow her/himself to be  picked up without protest? 
1   2   3   4   5   6   7   X . . . . (164) cry when the visitor attempted to pick her/him up? 
 
When in a crowd of people, how often did the baby:  




Did the baby seem sad when: 
1   2   3   4   5   6   7   X . . . . (166) caregiver is gone for an unusually long period of 
time? 
1   2   3   4   5   6   7   X . . . . (167) left alone/unattended in a crib or a playpen for an 
        extended period of time? 
 
When you were busy with another activity, and your baby was not able to get your 
attention, how often did s/he: 
1   2   3   4   5   6   7   X . . . . (168) become sad? 
1   2   3   4   5   6   7   X . . . . (169) cry? 
 
When your baby saw another baby crying, how often did s/he:  
1   2   3   4   5   6   7   X . . . . (170) become tearful? 
1   2   3   4   5   6   7   X . . . . (171) show distress? 
 
When familiar relatives/friends came to visit, how often did your baby: 
1   2   3   4   5   6   7   X . . . . (172) get excited? 





Have you tried any of the following soothing techniques in the last two weeks? If  so, 
how quickly did your baby soothe using each of these techniques? Circle (X) if you did 
not try the technique during the LAST TWO WEEKS. 
 
When rocking your baby, how often did s/he: 
1  2  3  4  5  6  7  X . . . . (174) soothe immediately? 
1  2  3  4  5  6  7  X . . . . (175) not soothe immediately, but in the first two minutes? 
1  2  3  4  5  6  7  X . . . . (176) take more than 10 minutes to soothe? 
 
When singing or talking to your baby, how often did s/he: 
1  2  3  4  5  6  7  X . . . . (177) soothe immediately? 
1  2  3  4  5  6  7  X . . . . (178) not soothe immediately, but in the first two minutes? 
1  2  3  4  5  6  7  X . . . . (179) take more than 10 minutes to soothe? 
 
When walking with the baby, how often did s/he: 
1  2  3  4  5  6  7  X . . . . (180) soothe immediately? 
1  2  3  4  5  6  7  X . . . . (181) not soothe immediately, but in the first two minutes? 
1  2  3  4  5  6  7  X . . . . (182) take more than 10 minutes to soothe? 
 
When giving him/her a toy, how often did the baby: 
1  2  3  4  5  6  7  X . . . . (183) soothe immediately? 
1  2  3  4  5  6  7  X . . . . (184) not soothe immediately, but in the first two minutes? 





When showing the baby something to look at, how often did s/he: 
1  2  3  4  5  6  7  X . . . . (186) soothe immediately? 
1  2  3  4  5  6  7  X . . . . (187) not soothe immediately, but in the first two minutes? 
1  2  3  4  5  6  7  X . . . . (188) take more than 10 minutes to soothe? 
 
When patting or gently rubbing some part of the baby’s body, how often did s/he: 
1  2  3  4  5  6  7  X . . . . (189) soothe immediately? 
1  2  3  4  5  6  7  X . . . . (190) not soothe immediately, but in the first two minutes? 
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